Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Conditions:   Metastatic Clear Cell Renal Cell Carcinoma;   Metastatic Renal Cell Carcinoma;   Stage IV Renal Cell Cancer AJCC v8 Interventions:   Procedure: Cytoreductive Nephrectomy;   Drug: Active Comparator Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials